血栓性动静脉通路的血管内挽救治疗结局及血栓切除术后通畅率的预测因素
本研究回顾性分析了294例血液透析患者血栓性动静脉通路的血管内挽救治疗,技术成功率和临床成功率分别为96.3%和93.2%,主要和次要并发症率为0.7%和9.9%。血栓切除术后3个月和6个月的一期通畅率分别为62.9%和43.9%。多因素分析显示90天内既往血栓形成与一期、辅助一期和二期通畅率丢失显著相关。
要点
- 血管内技术可挽救大多数血栓性动静脉通路,技术成功率达96.3%。
- 90天内复发性血栓形成是通畅率不良的独立预测因素。
- 动静脉移植物与一期通畅率负相关。
核心结论
- 大多数血栓性动静脉通路可通过血管内技术挽救。
- 90天内复发性血栓形成与短期和长期通畅率不良相关,即使血管内再干预成功。
研究设计与样本
- 回顾性综述接受血管内挽救治疗的血液透析患者记录,共294例,其中156例为动静脉瘘,138例为动静脉移植物。
主要发现
- 技术和临床成功率分别为96.3%和93.2%,主要和次要并发症率分别为0.7%和9.9%。
- 血栓切除术后3个月一期、辅助一期和二期通畅率分别为62.9%、76.2%和77.6%,6个月分别为43.9%、59.5%和61.6%。
- 除6个月辅助一期和二期通畅率外,动静脉瘘的通畅率显著优于动静脉移植物。
- 动静脉移植物也与一期通畅率负相关。
临床怎么用
- 血管内技术可作为血栓性动静脉通路的挽救治疗选择。
- 对于90天内发生复发性血栓的患者,应预期通畅率较差,需加强监测和个体化干预策略。
局限性
- 回顾性研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to report the outcomes of endovascular salvage of clotted arteriovenous (AV) accesses and to determine potential predictors of poor patency rates after thrombectomy. METHODS: Records of hemodialysis patients who underwent endovascular salvage of clotted AV access were reviewed retrospectively. Technical and clinical success rates, complication rates, and 3- and 6-month patency rates were determined. Multivariate analysis was performed to determine the predictors of patency after thrombectomy. RESULTS: A total of 294 patients underwent endovascular salvage of clotted AV access during the study period; 156 patients had arteriovenous fistula, whereas the remaining 138 were arteriovenous grafts (AVGs). The technical and clinical success rates were 96.3% and 93.2%; the major and minor complication rates were 0.7% and 9.9%. Post-thrombectomy primary, assisted primary, and secondary patency rates were 62.9%, 76.2%, and 77.6% at 3 months and 43.9%, 59.5%, and 61.6% at 6 months. The patency rates were significantly better for arteriovenous fistula than for AVG except for 6-month assisted primary and secondary patency. Multivariate Cox regression analysis showed that prior thrombosis within 90 days was significantly associated with loss of primary patency (hazard ratio [HR], 1.90; 95% confidence interval [CI], 1.21-2.98; P < .01), assisted primary patency (HR, 2.42; 95% CI, 1.42-4.13; P < .01), and secondary patency (HR, 2.52; 95% CI, 1.40-4.53; P < .01). Having an AVG was also negatively associated with primary patency. CONCLUSIONS: Most clotted AV accesses can be salvaged by endovascular technique. Recurrent thrombosis within 90 days is associated with poor short- and long-term patency even after successful endovascular reinterventions.
引用
- Tan RY, Pang SC, Teh SP, et al. Outcomes of endovascular salvage of clotted arteriovenous access and predictors of patency after thrombectomy. J Vasc Surg. 2019. PMID: 31492611. doi:10.1016/j.jvs.2019.07.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。